The DTaP vaccination series is an FDA-approved, five-shot vaccine for young children in the United States for protection against diphtheria, tetanus, and pertussis. DTaP stands for diphtheria, tetanus, and acellular pertussis, which are all common childhood diseases. In the US, Daptacel and Infanrix are the two types of DTaP vaccines, whereas other countries offer other variations. Both Daptacel and Infanrix consist of five shots that stimulate the immune system to protect a child against those diseases. Children vaccinated with DTaP may still end up getting one of the diseases, but they often present with milder symptoms than if they were not vaccinated. The general vaccination schedule for the five shot series is two months, four months, six months, fifteen to eighteen months, and four to six years of age. DTaP vaccination fully protects nine out of ten children against acquiring disease, contributing to a downward trend in diphtheria, tetanus, and pertussis cases in developing children in the US.

Heinrich Hermann Robert Koch was a researcher from Germany who studied the causative agents of infectious diseases in various parts of Europe, Africa, and Asia during the late nineteenth and early twentieth centuries. Koch developed what researchers call Koch’s postulates, which are four criteria designed to establish whether a bacterium causes a certain disease, and as of 2025, many researchers still use Koch’s postulates to guide their research. He also received the Nobel Prize in Physiology or Medicine for his discovery of Mycobacterium tuberculosis, which is the bacterium responsible for tuberculosis, an infectious disease that primarily attacks the lungs. Koch’s research on identifying disease-causing bacteria for various infectious diseases has advanced disease prevention and treatment, especially for tuberculosis, which has the ability to transmit from mother to child.